Table 2. In vitro growth inhibition of cancer cell lines by KuWal151 (8c)a.
| Cell line | Cancer origin | GI50 [μM] | SPF45b [FPKM]c | CLK1 [FPKM]c |
| 786–0 | Renal Cancer | 0.275 | 18 | 13 |
| A498 | Renal Cancer | 0.166 | 10 | 9 |
| A549/ATCC | Non-Small Cell Lung Cancer | 0.389 | 16 | 11 |
| ACHN | Renal Cancer | 0.372 | 15 | 6 |
| BT-549 | Breast Cancer | 0.204 | n.a. | n.a. |
| CCRF-CEM | Leukemia | 0.178 | n.a. | n.a. |
| COLO 205 | Colon Cancer | 0.209 | n.a. | n.a. |
| DU-145 | Prostate Cancer | 0.316 | 22 | 7 |
| EKVX | Non-Small Cell Lung Cancer | 0.355 | 19 | 12 |
| HCC-2998 | Colon Cancer | 0.912 | n.a | n.a |
| HCT-116 | Colon Cancer | 0.191 | 22 | 9 |
| HCT-15 | Colon Cancer | 0.178 | 25 | 15 |
| HL-60(TB) | Leukemia | 0.141 | 9 | 14 |
| HOP-92 | Non-Small Cell Lung Cancer | 5.62 | 19 | 7 |
| HS 578T | Breast Cancer | 0.204 | 6 | 8 |
| HT29 | Colon Cancer | 0.174 | 19 | 15 |
| IGROV1 | Ovarian Cancer | 0.427 | 21 | 11 |
| K-562 | Leukemia | 0.162 | 18 | 9 |
| KM12 | Colon Cancer | 0.209 | 20 | 39 |
| LOX IMVI | Melanoma | 0.245 | 17 | 17 |
| M14 | Melanoma | 0.132 | n.a | n.a |
| MCF7 | Breast Cancer | 0.174 | 19 | 11 |
| MDA-MB-231/ATCC | Breast Cancer | 1.38 | 18 | 14 |
| MDA-MB-435 | Melanoma | 0.0724 | 11 | 22 |
| MDA-MB-468 | Breast Cancer | 0.234 | 20 | 11 |
| MOLT-4 | Leukemia | 0.257 | n.a | n.a |
| NCI/ADR-RES | Ovarian Cancer | 0.178 | n.a | n.a |
| NCI-H226 | Non-Small Cell Lung Cancer | 28.8 | 8 | 6 |
| NCI-H23 | Non-Small Cell Lung Cancer | 0.525 | 25 | 12 |
| NCI-H322M | Non-Small Cell Lung Cancer | 2.39 | 7 | 13 |
| NCI-H460 | Non-Small Cell Lung Cancer | 0.209 | 15 | 4 |
| NCI-H522 | Non-Small Cell Lung Cancer | 0.158 | 9 | 15 |
| OVCAR-3 | Ovarian Cancer | 0.191 | 12 | 11 |
| OVCAR-4 | Ovarian Cancer | 0.912 | 15 | 9 |
| OVCAR-5 | Ovarian Cancer | 1.25 | n.a | n.a |
| OVCAR-8 | Ovarian Cancer | 0.724 | 36 | 10 |
| PC-3 | Prostate Cancer | 0.339 | 12 | 15 |
| RPMI-8226 | Leukemia | 0.288 | 19 | 10 |
| RXF 393 | Renal Cancer | 0.457 | n.a | n.a |
| SF-268 | CNS Cancer | 0.437 | 12 | 5 |
| SF-295 | CNS Cancer | 0.224 | 11 | 8 |
| SF-539 | CNS Cancer | 0.166 | 12 | 12 |
| SK-MEL-2 | Melanoma | 0.316 | n.a | n.a |
| SK-MEL-28 | Melanoma | 0.692 | 8 | 12 |
| SK-MEL-5 | Melanoma | 0.407 | 9 | 9 |
| SK-OV-3 | Ovarian Cancer | 0.275 | 20 | 9 |
| SN12C | Renal Cancer | 0.331 | n.a | n.a |
| SNB-19 | CNS Cancer | 0.389 | n.a | n.a |
| SNB-75 | CNS Cancer | 0.151 | 10 | 11 |
| SR | Leukemia | 0.151 | n.a | n.a |
| SW-620 | Colon Cancer | 0.209 | 22 | 17 |
| T-47D | Breast Cancer | 0.309 | 20 | 7 |
| TK-10 | Renal Cancer | 10.2 | n.a | n.a |
| U251 | CNS Cancer | 0.263 | n.a | n.a |
| UACC-257 | Melanoma | >50.1 | 8 | 12 |
| UACC-62 | Melanoma | 0.275 | 10 | 12 |
| UO-31 | Renal Cancer | 0.832 | 10 | 6 |
a n.a. = not available
b synonym in Expression Atlas: RBM17
c FPKM (fragments per kilobase of exon model per million reads mapped) is a common unit of gene expression calculated from RNA-sequencing data. The calculation takes into account gene length and total number of mapped reads [46].